Peptide Plug

Age Verification

Peptide Plug is a research and organization tool intended for adults 18 years of age or older. By continuing, you confirm you are at least 18.

Reference only · Not medical advice · For adults 18+ · No dosing information is published here
Peptide Plug
HomeResearchEducationToolsGuidesCompareAboutOpen the App
Home/Research library/Hexarelin / Cjc-1295 Blend
GH Secretagogues

Hexarelin / Cjc-1295 Blend — reference

Combines a potent GHRP with a GHRH analogue.

Regulatory statusNot FDA-Approved
Published half-lifeReflects both components (~70–150min hexarelin, ~30min or ~7d CJC depending on variant)
Evidence levelLimited data
CategoryGH Secretagogues

Regulatory status

Not FDA-Approved. Not an approved product; both components are research chemicals in the US.

Reported cautions

⚠ Worth knowing. Hexarelin's rapid tolerance means the blend's effect fades faster than a CJC/ipamorelin pairing. Higher cortisol and prolactin impact than the more selective combinations.

Pharmacokinetics

Published figures give an elimination half-life of Reflects both components (~70–150min hexarelin, ~30min or ~7d CJC depending on variant). Wide range depending on whether DAC or no-DAC CJC is used — worth surfacing that distinction in the UI.

This figure is tagged Limited data in our evidence system. The available data does not support a confident single figure, so this entry is flagged accordingly. Read any curve built from it as illustrative only. You can see the shape this implies between doses in the Half-Life Visualizer, and compare it against every other compound in the Half-Life Data Table. Our sourcing page explains what each tier means.

Remember that an estimated curve is a model built from a population figure, not a measurement of your blood. Individual clearance varies, and for depot injections the figure describes release from the injection site rather than the compound clearing. Half-life explained →

What Peptide Plug does and does not publish

This page carries regulatory status, general context and published pharmacokinetics. It carries no dose, frequency or cycle information — that is a deliberate editorial line, because dosing is a clinical decision rather than reference data. We also do not sell, supply, source or link to vendors for any compound.

Frequently asked

Is Hexarelin / Cjc-1295 Blend FDA-approved?
Not FDA-Approved. Not an approved product; both components are research chemicals in the US.
What is the half-life of Hexarelin / Cjc-1295 Blend?
Published figures give Reflects both components (~70–150min hexarelin, ~30min or ~7d CJC depending on variant). Wide range depending on whether DAC or no-DAC CJC is used — worth surfacing that distinction in the UI.
How reliable is that half-life figure?
It is tagged “Limited data” in our system. The available data does not support a confident single figure, so this entry is flagged accordingly. Read any curve built from it as illustrative only.
What cautions are associated with Hexarelin / Cjc-1295 Blend?
Hexarelin's rapid tolerance means the blend's effect fades faster than a CJC/ipamorelin pairing. Higher cortisol and prolactin impact than the more selective combinations.
Does Peptide Plug publish dosing for Hexarelin / Cjc-1295 Blend?
No. This library publishes regulatory status, general context and pharmacokinetics only. Dose, frequency and cycle information is deliberately absent from these public pages — those are clinical decisions, not reference data.
Does Peptide Plug sell Hexarelin / Cjc-1295 Blend?
No. We do not sell, supply, source or link to vendors for any compound, and we have no affiliate arrangements with suppliers. Peptide Plug is a tracking and calculation tool.

Related tools

Free, no account required.

Half-Life Visualizer
Estimated rise-and-fall curve between doses.
Reconstitution Calculator
Vial math including blend support.
Medication Storage Calculator
Discard windows from published guidance.
Half-Life Data Table
All 86 compounds with evidence tags.
Pro Protocol Reference

The public research page intentionally does not publish dosing. Pro subscribers can open the separate Protocol Library for structured indication, frequency, duration, notes, and review-first Cycle Builder import when a matching reference is available.

View Protocol Reference
Reference information, not medical advice. This page describes regulatory status and published pharmacokinetics. It does not tell you whether to use this compound, how much to use, how often, or whether it is safe for you. Peptide Plug does not sell, supply or source any compound. Those decisions belong to you and a licensed clinician.

Part of the Peptide Plug research library · How we source our figures · All compounds A–Z